C030037F17Rik Inhibitors
C030037F17Rik, stemming from the RIKEN cDNA C030037F17 gene, plays a pivotal role in cellular processes, potentially involving gene expression regulation. While direct inhibitors for C030037F17Rik remain unidentified, exploration of potential inhibitors targeting key signaling pathways unveils promising avenues for further investigation. Functionally, C030037F17Rik's intricate involvement in cellular processes is intricately linked to the PI3K-AKT, mTOR, GSK-3, AMPK, JNK, and MEK pathways. These pathways collectively contribute to cellular responses and gene expression dynamics associated with C030037F17Rik. The indirect inhibitors identified, such as AZD5363, CCT137690, and PD0325901, modulate these pathways to potentially impact the regulatory mechanisms and gene expression dynamics associated with C030037F17Rik.
The PI3K-AKT pathway, a key regulator of cellular survival and proliferation, mTOR pathway, crucial for cellular growth and protein synthesis, GSK-3 signaling, AMPK pathway involved in cellular energy regulation, JNK pathway modulating stress responses, and MEK pathway influencing cell growth and differentiation collectively contribute to the intricate role of C030037F17Rik in cellular homeostasis. The identified inhibitors target these pathways, providing a foundation for future investigations into the regulatory intricacies of C030037F17Rik and its potential modulation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $180.00 $726.00 $1055.00 $3350.00 $5200.00 | 23 | |
A769662, an AMP-activated protein kinase (AMPK) activator, influences C030037F17Rik indirectly by modulating cellular energy states through AMPK activation. This activation may impact the regulatory mechanisms associated with C030037F17Rik, potentially altering gene expression dynamics. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
AZD5363, an AKT kinase inhibitor, modulates the PI3K-AKT pathway to intricately influence cellular processes linked to C030037F17Rik. Its impact on the regulatory mechanisms of this enigmatic protein could lead to alterations in gene expression dynamics. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $153.00 $520.00 | 4 | |
GSK-3 Inhibitor XVI may influence C030037F17Rik by disrupting GSK-3 signaling, impacting downstream cellular responses and potentially altering gene expression dynamics associated with this enigmatic protein. | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $184.00 $195.00 | 2 | |
GDC-0941, a PI3K inhibitor, disrupts the PI3K-AKT pathway, potentially influencing cellular processes linked to C030037F17Rik. Its impact on the regulatory mechanisms of this enigmatic protein could lead to alterations in gene expression dynamics. | ||||||
Strontium Ranelate | 135459-87-9 | sc-208403 | 10 mg | $320.00 | ||
Strontium Ranelate may indirectly influence C030037F17Rik by suppressing c-Jun N-terminal kinase activity, impacting gene expression dynamics associated with this enigmatic protein through modulation of cellular stress responses. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $178.00 $325.00 | 67 | |
MK-2206, an allosteric AKT inhibitor, may intricately influence cellular processes associated with C030037F17Rik by modulating the PI3K-AKT pathway. Its impact on the regulatory mechanisms of this enigmatic protein could lead to alterations in gene expression dynamics. | ||||||
TMP269 | 1314890-29-3 | sc-475375 | 5 mg | $340.00 | ||
TMP269 influences C030037F17Rik indirectly by modulating cellular energy states through AMPK inhibition. This inhibition may impact the regulatory mechanisms associated with C030037F17Rik, potentially altering gene expression dynamics. | ||||||
PIK-75, hydrochloride | 372196-77-5 | sc-296089 sc-296089A | 1 mg 5 mg | $28.00 $122.00 | ||
PIK-75, a dual PI3K/mTOR inhibitor, disrupts the PI3K-AKT pathway, potentially influencing cellular processes linked to C030037F17Rik. Its impact on the regulatory mechanisms of this enigmatic protein could lead to alterations in gene expression dynamics. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580, acting as a p38 MAP kinase inhibitor, may indirectly influence C030037F17Rik by altering the dynamics of cellular responses crucial for this enigmatic protein through modulation of the MAPK pathway, particularly p38 MAP kinase. | ||||||
Torin 1 | 1222998-36-8 | sc-396760 | 10 mg | $240.00 | 7 | |
Torin 1, a dual mTOR inhibitor, may indirectly impact C030037F17Rik by targeting mTOR-dependent cellular processes, potentially altering the landscape of gene expression and the regulatory mechanisms associated with this protein. | ||||||